PUBLISHER: GlobalData | PRODUCT CODE: 1689001
PUBLISHER: GlobalData | PRODUCT CODE: 1689001
Ophthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Ophthalmic Devices therapeutic area.
Ophthalmic Viscoelastic Devices are essential tools in ocular surgery, especially in anterior segment surgery. Ophthalmic Viscoelastic Devices provide the viscoelastic materials used to maintain space in the eye during surgery.
Ophthalmic Viscoelastic Devices, also known as OVDs, are devices used during intraocular surgery and are primary composed of sodium hyaluronate, chondroitin sulphate, or hydroxypropyl methylcellulose. These devices protect delicate ocular structures and reduce post operational complications such as corneal edema. OVDs help maintain pressure in the anterior chamber of the eyes and prevent iris prolapse by maintaining compartmentalization of the eyes. The use of these devices significantly reduces patient recovery times. They are often used in cataract surgeries, including extracapsular and phacoemulsification surgeries.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Ophthalmic Viscoelastic Devices (OVD) and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Carl Zeiss Meditec AG, Bausch & Lomb Inc, Johnson & Johnson Vision Care Inc, Alcon Inc, Rayner Intraocular Lenses Ltd, Aurolab, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable